İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2019 · article

The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever

YÖKSİS OpenAlex Açık erişim · diamond TR Index
Yıl2019
Atıf11OpenAlex
Yüzdelik%71,2
FWCI0,821,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıTurkish Journal Of Medical Sciences
  • Katalog eşleşmesi (ISSN)Turkish Journal of Medical Sciences
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Background/aim: Crimean-Congo hemorrhagic fever (CCHF) is a serious illness characterized by fever and hemorrhage. Endothelin-1 (ET-1), angiopoietin-2 (Ang-2), and endothelial cell-specific receptor tyrosine kinase (Tie-2) are believed to be important markers of the pathogenesis, clinical course, and prognosis of the disease. The aim of this study was to determine ET-1, Ang-2, and Tie-2 levels in adults with CCHF and investigate the associations between these markers and pathogenesis and disease course. Materials and methods: Sixty CCHF patients were included in the study. The patients were classified according to disease severity criteria and Ang-2, Tie-2, and ET-1 levels were compared. Results: Mean serum ET-1 level was 36.62 ± 27.99 pg/mL in the patient group and 3.70 ± 4.71 pg/mL in the control group (P = 0.001). Mean serum Ang-2 levels were 2511.18 ± 1018.64 pg/mL in the patient group and 3570.76 ± 209.52 pg/mL in the control group (P = 0.001). Mean serum Tie-2 levels were 7.35 ± 7.75 ng/mL in the patient group and 0.67 ± 1.26 ng/mL in the control group (P = 0.001). Conclusion: Elevated ET-1 and Tie-2 levels were associated with more severe disease course, while Ang-2 level was negatively correlated with severity in adult CCHF patients. ET-1, Tie-2, and Ang-2 levels are important prognostic parameters in CCHF and may contribute significantly to treatment and follow-up.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

11atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 22 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2021 The Association Between Procalcitonin, Lactate Level, and Clinical Prognosis in Patients with Crimean-Congo Hemorrhagic FeverAtıf 6 · OpenAlex
  2. 2021 The Association Between Procalcitonin, Lactate Level, and Clinical Prognosis in Patients with Crimean-Congo Hemorrhagic FeverAtıf 6 · OpenAlex
  3. 2021 Diagnosis, Prognosis and Clinical Trial in Crimean-Congo Hemorrhagic FeverAtıf 5 · OpenAlex
  4. 2022 Role of TGF-β1 and PDGF-B in Crimean-Congo Hemorrhagic Fever in Eastern Anatolia Region in TurkeyAtıf 3 · OpenAlex
  5. 2022 Role of TGF-β1 and PDGF-B in Crimean-Congo Hemorrhagic Fever in Eastern Anatolia Region in TurkeyAtıf 3 · OpenAlex
  6. 2022 Role of TGF-β1 and PDGF-B in Crimean-Congo Hemorrhagic Fever in Eastern Anatolia Region in TurkeyAtıf 3 · OpenAlex
  7. 2022 Role of TGF-β1 and PDGF-B in Crimean-Congo Hemorrhagic Fever in Eastern Anatolia Region in TurkeyAtıf 3 · OpenAlex
  8. 2025 The effect of VEGF and KDR gene variants on Crimean-Congo hemorrhagic fever.Atıf 2 · OpenAlex
  9. 2025 The effect of VEGF and KDR gene variants on Crimean-Congo hemorrhagic feverAtıf 2 · OpenAlex
  10. 2025 The effect of VEGF and KDR gene variants on Crimean-Congo hemorrhagic feverAtıf 2 · OpenAlex

Yazarlar

4
  1. FERHAN KERGET 1
  2. ZÜLAL ÖZKURT ATATÜRK ÜNİVERSİTESİ 2
  3. NURİNNİSA ÖZTÜRK ATATÜRK ÜNİVERSİTESİ 3
  4. SİNAN YILMAZ ATATÜRK ÜNİVERSİTESİ 4